{
  "image_filename": "table_p13_det_12_007.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/table_p13_det_12_007.png",
  "image_type": "Table",
  "page_number": 13,
  "block_id": "det_12_007",
  "claim_id": "claim_001",
  "claim": "Flublok contains 3x the hemagglutinin (HA) antigen content of standard-dose flu vaccines, which has been linked to greater immunogenicity vs standard-dose flu vaccines.",
  "supports_claim": false,
  "explanation": "Table listing trade names and dose volumes (\u00b5g HA per vaccine virus) for quadrivalent influenza vaccines in children aged 6 through 35 months, showing Afluria Quadrivalent 0.25 mL (7.5 \u00b5g) and several others at 0.5 mL (15 \u00b5g) does not support the claim because the table does not include Flublok or any indication that it contains three times the HA antigen content versus standard-dose vaccines",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Table listing trade names and dose volumes (\u00b5g HA per vaccine virus) for quadrivalent influenza vaccines in children aged 6 through 35 months, showing Afluria Quadrivalent 0.25 mL (7.5 \u00b5g) and several others at 0.5 mL (15 \u00b5g)",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table does not include Flublok or any indication that it contains three times the HA antigen content versus standard-dose vaccines",
    "confidence_notes": null
  }
}